Does perioperative immunotherapy reduce the risk of second primary cancers?

Marco Tagliamento, Jordi Remon, David Planchard, Benjamin Besse

Résultats de recherche: Contribution à un journal › Editorial

1 Citation (Scopus)

langue originale	Anglais
Numéro d'article	113355
journal	European Journal of Cancer
Volume	194
Les DOIs	https://doi.org/10.1016/j.ejca.2023.113355
état	Publié - 1 nov. 2023

Accès au document

10.1016/j.ejca.2023.113355

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{21ed9d1f047044df9428354e391188a7,

title = "Does perioperative immunotherapy reduce the risk of second primary cancers?",

keywords = "Adjuvant, Immune checkpoint inhibitors, Immunoprevention, Immunotherapy, Neoadjuvant, Second primary cancers",

author = "Marco Tagliamento and Jordi Remon and David Planchard and Benjamin Besse",

year = "2023",

month = nov,

day = "1",

doi = "10.1016/j.ejca.2023.113355",

language = "English",

volume = "194",

journal = "European Journal of Cancer",

issn = "0959-8049",

}

TY - JOUR

T1 - Does perioperative immunotherapy reduce the risk of second primary cancers?

AU - Tagliamento, Marco

AU - Remon, Jordi

AU - Planchard, David

AU - Besse, Benjamin

PY - 2023/11/1

Y1 - 2023/11/1

KW - Adjuvant

KW - Immune checkpoint inhibitors

KW - Immunoprevention

KW - Immunotherapy

KW - Neoadjuvant

KW - Second primary cancers

UR - http://www.scopus.com/inward/record.url?scp=85173260930&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2023.113355

DO - 10.1016/j.ejca.2023.113355

M3 - Editorial

AN - SCOPUS:85173260930

SN - 0959-8049

VL - 194

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 113355

ER -